Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PYRIDOSTIGMINE Cause Product substitution issue? 33 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Product substitution issue have been filed in association with PYRIDOSTIGMINE (pyridostigmine bromide). This represents 1.7% of all adverse event reports for PYRIDOSTIGMINE.

33
Reports of Product substitution issue with PYRIDOSTIGMINE
1.7%
of all PYRIDOSTIGMINE reports
0
Deaths
4
Hospitalizations

How Dangerous Is Product substitution issue From PYRIDOSTIGMINE?

Of the 33 reports, 4 (12.1%) required hospitalization, and 1 (3.0%) were considered life-threatening.

Is Product substitution issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PYRIDOSTIGMINE. However, 33 reports have been filed with the FAERS database.

What Other Side Effects Does PYRIDOSTIGMINE Cause?

Drug ineffective (322) Off label use (238) Myasthenia gravis (193) Diarrhoea (167) Asthenia (129) Fatigue (110) Condition aggravated (99) Nausea (86) Dyspnoea (85) Headache (81)

What Other Drugs Cause Product substitution issue?

AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832) BUPROPION (1,578) METHYLPHENIDATE (1,408) CLONAZEPAM (1,288) LAMOTRIGINE (979) ALBUTEROL (864) LEVOTHYROXINE (803) DULOXETINE (766) ESTRADIOL (692) SERTRALINE (636)

Which PYRIDOSTIGMINE Alternatives Have Lower Product substitution issue Risk?

PYRIDOSTIGMINE vs PYRIDOXINE PYRIDOSTIGMINE vs PYRIDOXINE\THIAMINE PYRIDOSTIGMINE vs PYRIMETHAMINE PYRIDOSTIGMINE vs PYROTINIB PYRIDOSTIGMINE vs QSYMIA

Related Pages

PYRIDOSTIGMINE Full Profile All Product substitution issue Reports All Drugs Causing Product substitution issue PYRIDOSTIGMINE Demographics